NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 10, 2025 $3.19 -2.47% $3.06 V 95.78% 1
Apr 10, 2025 $4.56 +39.45% $3.06 X 50.98% 0
Jan 28, 2025 Bullish $6.19 X 0
Jan 23, 2025 $5.81 -3.05% $6.19 X 93.82% 0
Jan 23, 2025 $5.88 -1.90% $6.19 X 94.93% 0
Jan 23, 2025 Bullish $6.19 V 1
Jan 21, 2025 $5.72 -3.17% $5.88 V 97.33% 1
Jan 21, 2025 $6.03 +1.98% $5.88 X 97.50% 0
Jan 21, 2025 Bullish $5.88 X 0
May 15, 2024 $10.94 +2.06% $10.68 X 97.56% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE